Abiopharma

🔍 Arno Andrew (Director)

Company: Insight Molecular Diagnostics Inc. (IMDX)

Report Date: 2026-06-11

Detailed Transactions and Holdings:

• Acquired 32,331 shares of Common Stock, no par value (Direct)
  Date: 2026-06-11 | Code: A | equity_swap_involved: 0 | shares_owned_after: 168,885.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Common Stock, no par value (Direct)
  Date: 2026-06-11 | Code: H | nature_of_ownership: See footnote | shares_owned_after: 7,804.00 | Footnotes: F2
• Holds 0 shares of Common Stock, no par value (Direct)
  Date: 2026-06-11 | Code: H | nature_of_ownership: See footnote | shares_owned_after: 7,804.00 | Footnotes: F3

Footnotes:

• F1: The Restricted Stock Units shall vest on the date of the next annual meeting of shareholders, subject to the Reporting Person's continued service from the date of grant until the vesting date.
• F2: These shares of Common Stock are held by JBA Investments LLC ("JBA"). The Reporting Person is the Manager of JBA and, in such capacity, has the right to vote and dispose of securities held by JBA, including the shares of Common Stock reported here.
• F3: These shares of Common Stock are held by MJA Investments LLC ("MJA"). The Reporting Person is the Manager of MJA and, in such capacity, has the right to vote and dispose of securities held by MJA, including the shares of Common Stock reported here.